XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2020
Segment Information [Abstract] |
Segment Information | 14. Segment Information We have two reportable segments organized according to our products and services: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue, JOTEC, On-X, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues and NeoPatch. There are no intersegment revenues. The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands):
| Three Months Ended |  | Six Months Ended
| June 30, |  | June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Revenues: |  |  |  |  |  |  |  |  |  |  |
Medical devices | $ | 37,268 |  | $ | 51,168 |  | $ | 83,688 |  | $ | 99,569
Preservation services |  | 16,503 |  |  | 19,971 |  |  | 36,512 |  |  | 39,075
Total revenues |  | 53,771 |  |  | 71,139 |  |  | 120,200 |  |  | 138,644
Cost of products and preservation services: |  |  |  |  |  |  |  |  |  |  |
Medical devices |  | 10,040 |  |  | 14,489 |  |  | 23,080 |  |  | 28,315
Preservation services |  | 7,841 |  |  | 9,684 |  |  | 17,059 |  |  | 19,090
Total cost of products and preservation services |  | 17,881 |  |  | 24,173 |  |  | 40,139 |  |  | 47,405
Gross margin: |  |  |  |  |  |  |  |  |  |  |
Medical devices |  | 27,228 |  |  | 36,679 |  |  | 60,608 |  |  | 71,254
Preservation services |  | 8,662 |  |  | 10,287 |  |  | 19,453 |  |  | 19,985
Total gross margin | $ | 35,890 |  | $ | 46,966 |  | $ | 80,061 |  | $ | 91,239
The following table summarizes net revenues by product and service (in thousands):
| Three Months Ended |  | Six Months Ended
| June 30, |  | June 30,
| 2020 |  | 2019 |  | 2020 |  | 2019
Products: |  |  |  |  |  |  |  |  |  |  |
BioGlue | $ | 12,437 |  | $ | 17,933 |  | $ | 29,174 |  | $ | 35,155
JOTEC |  | 13,174 |  |  | 17,208 |  |  | 28,642 |  |  | 33,162
On-X |  | 10,116 |  |  | 12,410 |  |  | 22,318 |  |  | 24,141
PhotoFix |  | 880 |  |  | 935 |  |  | 1,922 |  |  | 1,665
PerClot |  | 497 |  |  | 784 |  |  | 1,357 |  |  | 1,834
CardioGenesis cardiac laser therapy |  | 164 |  |  | 1,898 |  |  | 275 |  |  | 3,612
Total products |  | 37,268 |  |  | 51,168 |  |  | 83,688 |  |  | 99,569
Preservation services: |  |  |  |  |  |  |  |  |  |  |
Cardiac tissue |  | 8,061 |  |  | 10,500 |  |  | 18,079 |  |  | 19,430
Vascular tissue |  | 8,396 |  |  | 9,471 |  |  | 18,372 |  |  | 19,645
NeoPatch |  | 46 |  |  | -- |  |  | 61 |  |  | --
Total preservation services |  | 16,503 |  |  | 19,971 |  |  | 36,512 |  |  | 39,075
Total revenues | $ | 53,771 |  | $ | 71,139 |  | $ | 120,200 |  | $ | 138,644

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration